INIS
patients
100%
cancer
100%
breasts
100%
skin
100%
genetics
100%
radiotherapy
100%
genes
75%
tissues
50%
risks
37%
toxicity
37%
interactions
25%
antioxidants
12%
reduction
12%
inflammation
12%
cytokines
12%
increasing
12%
cell cycle
12%
regulations
12%
additives
12%
dna
12%
biological markers
12%
skin damage
12%
rna
12%
polymerase chain reaction
12%
nucleotides
12%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Toxicity
100%
Skin Manifestation
100%
Adverse Event
66%
Malignant Neoplasm
33%
Biological Marker
33%
Binding Site
33%
Cytokine
33%
microRNA
33%
Skin Defect
33%
Antioxidant
33%
Biochemistry, Genetics and Molecular Biology
Genetic Divergence
100%
CD44
100%
Allele
40%
MicroRNA
20%
Genetics
20%
Single-Nucleotide Polymorphism
20%
Genetic Polymorphism
20%
RAD17
20%
TaqMan
20%
MAP3K7
20%
ALAD
20%
Inflammatory Cytokine
20%
XRCC1
20%
Real-Time Polymerase Chain Reaction
20%
Binding Site
20%
Gene Mutation
20%
Multifactor Dimensionality Reduction
20%
RNA Binding
20%
NFE2L2
20%
Cell Cycle Regulation
20%
Immunology and Microbiology
CD44
100%
Allele
40%
Inflammatory Cytokine
20%
Real Time Polymerase Chain Reaction
20%
Single Nucleotide Polymorphism
20%
Multifactor Dimensionality Reduction
20%
Cell Cycle Regulation
20%
Gene Mutation
20%
RNA Binding
20%
Genetic Polymorphism
20%
Binding Site
20%